These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38274963)
1. Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study. Toora E; Kulkarni RG; Manivannan P; Sastry AS; Basavarajegowda A; Sahoo D Asian J Transfus Sci; 2023; 17(2):239-245. PubMed ID: 38274963 [TBL] [Abstract][Full Text] [Related]
2. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Singh RP; Marwaha N; Malhotra P; Dash S Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653 [TBL] [Abstract][Full Text] [Related]
3. A Comparative Assessment of Quality of Platelet Concentrates Prepared by Buffy Coat Poor Platelet Concentrate Method and Apheresis Derived Platelet Concentrate Method. Mallhi RS; Kumar S; Philip J Indian J Hematol Blood Transfus; 2015 Dec; 31(4):453-9. PubMed ID: 26306070 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of different types of platelet concentrates in thrombocytopenic patients. Singh RP; Marwaha N; Malhotra P; Dash S Indian J Hematol Blood Transfus; 2008 Mar; 24(1):16-22. PubMed ID: 23100935 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat. Li M; Zhao Y; Chen X; Du X; Luo Y; Li Y; Kang J; Wan L; Tang J; Fu X Transfusion; 2024 Feb; 64(2):367-379. PubMed ID: 38174435 [TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation. Fernández-Muñoz H; Plaza EM; Rivera-Caravaca JM; Candela MJ; Romera M; De Arriba F; Lozano ML; Vicente V; Heras I; Castilla-Llorente C; Rivera J Hematology; 2018 Oct; 23(9):712-718. PubMed ID: 29582705 [TBL] [Abstract][Full Text] [Related]
7. Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures. Noulsri E; Udomwinijsilp P; Lerdwana S; Chongkolwatana V; Permpikul P Transfus Apher Sci; 2017 Apr; 56(2):135-140. PubMed ID: 28029568 [TBL] [Abstract][Full Text] [Related]
8. Are Buffy-coat Pooled Platelet Concentrates an Effective Alternative to Apheresis Platelet Concentrates? An Agarwal P; Jain A; Elhence P; Verma A Int J Appl Basic Med Res; 2023; 13(3):175-179. PubMed ID: 38023597 [TBL] [Abstract][Full Text] [Related]
9. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr. Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917 [TBL] [Abstract][Full Text] [Related]
10. Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods. Kaur D; Sharma RR; Marwaha N Asian J Transfus Sci; 2015; 9(1):31-5. PubMed ID: 25722570 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the platelet-rich plasma and buffy coat protocols for preparation of canine platelet concentrates. Hoareau GL; Jandrey KE; Burges J; Bremer D; Tablin F Vet Clin Pathol; 2014 Dec; 43(4):513-8. PubMed ID: 25267468 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature. Ojha S; Tirlotkar A; Gupta AM; S H S; Chavan P; Poojary M Transfus Apher Sci; 2021 Feb; 60(1):103014. PubMed ID: 33262053 [TBL] [Abstract][Full Text] [Related]
13. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Muylle L; Wouters E; Peetermans ME Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775 [TBL] [Abstract][Full Text] [Related]
14. Serial changes in morphology and biochemical markers in platelet preparations with storage. Jain A; Marwaha N; Sharma RR; Kaur J; Thakur M; Dhawan HK Asian J Transfus Sci; 2015; 9(1):41-7. PubMed ID: 25722572 [TBL] [Abstract][Full Text] [Related]
15. Pooled platelet concentrates: an alternative to single donor apheresis platelets? Pietersz RN Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Therapeutic Effect of Apheresis Platelets and Buffy Coat-Derived Platelet Concentrates. Wang Z; Chen X; Zhang Y; Lu H; Ren L Clin Lab; 2024 Aug; 70(8):. PubMed ID: 39193950 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium. Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027 [TBL] [Abstract][Full Text] [Related]
18. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy. Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564 [TBL] [Abstract][Full Text] [Related]
19. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates. Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842 [TBL] [Abstract][Full Text] [Related]
20. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II). Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]